Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis Mehmet Saldir, Turan Tunc, Ferhat Cekmez, Merih Cetinkaya, Tugce Kalayci, Kursat Fidanci, Oguzhan Babacan, Galip Erdem, Necmettin Kocak, Erkan Sari, Emin Ozgur Akgul, Mustafa Kul Pediatrics & Neonatology Volume 56, Issue 6, Pages 415-421 (December 2015) DOI: 10.1016/j.pedneo.2015.03.006 Copyright © 2015 Terms and Conditions
Figure 1 (A)Serum levels of IL-6; (B) sTREM-1; (C) Endocan; and (D) I/T ratio in nonseptic group and septic neonates at the time of diagnosis (Sepsis 1) and 48−72 hours after initiation of treatment (Sepsis 2). Pediatrics & Neonatology 2015 56, 415-421DOI: (10.1016/j.pedneo.2015.03.006) Copyright © 2015 Terms and Conditions